ReviewFrontiers in neuroscience2026
The function of chemokine-driven glial-neuronal interaction in chronic pain.
Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic pain affects hundreds of millions worldwide, yet current treatments-from NSAIDs to opioids-fall short and bring unwanted side effects. Neuroinflammation drives bidirectional glial-neuronal communication, a core mechanism underlying central sensitization in chronic pain, with chemokines serving as key mediators. Most studies to date have zeroed in on isolated pathways or specific anatomical sites, missing the bigger picture. We pull together findings across the neural axis, spanning peripheral sensory ganglia, the spinal dorsal horn, and higher brain centers, then dissect the molecular machinery of chemokine-mediated crosstalk among microglia, astrocytes, and neurons. We trace downstream regulatory cascades through two major axes-CCL2/CCR2 and CX3CL1/CX3CR1-along with their effector branches (ERK-GluN2B, p38 MAPK-NF-κB), map out polarization phenotypes (M1/M2 for microglia, A1/A2 for astrocytes), and detail the functional shifts glia undergo in disease states. By knitting scattered observations into a unified regulatory map of chemokine signaling across the chronic pain neural network, this review addresses the field's persistent lack of systematic integration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.